Vivani Medical to Participate in Panel Discussion at the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vest
| June 14, 2023
Read More
Vivani Medical Reports First Quarter Financial Results and Provides Business Update
| May 15, 2023
Read More
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
| April 4, 2023
Read More
Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
| March 31, 2023
Read More
Vivani Medical Announces Public Filing of Registration Statement for the Proposed Initial Public Offering of Cortigent, Inc., a Subsidiary Advancing the Business of its Neuromodulation Division
vivani | March 21, 2023
Read More
Vivani Medical to Present at the ThinkEquity Investor Conference
vivani | November 14, 2022
Read More
Vivani Medical Reports Third Quarter 2022 Results and Provides Business Updates
vivani | November 14, 2022
Read More
Vivani Announces Trading under New Ticker Symbol (Nasdaq: VANI)
vivani | August 31, 2022
Read More
Second Sight Medical Products Announces Successful Completion of its Merger with Nano Precision Medical and its Name Change to Vivani Medical, Inc.
vivani | August 30, 2022
Read More
Second Sight Medical Products, Inc. Announces Shareholder Approval for Proposed Merger with Nano Precision Medical, Inc. and other Results of 2022 Annual Meeting
vivani | July 29, 2022
Read More
Blog Navigation
Contact Us
To learn more about Vivani or the upcoming First in Human trial of NPM-119 (GLP-1 implant), please fill out the form below.